3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Remotely supervised at-home delivery of taVNS for autism spectrum disorder: feasibility and initial efficacy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Transcutaneous auricular vagus nerve stimulation (taVNS) has potential clinical application for autism spectrum disorder (ASD). At-home sessions are necessary to allow delivery of repeated sessions, and remove burden on patients for daily visits, and reduce costs of clinic delivery. Our objective was to validate a protocol for remote supervised administration for home delivery of taVNS using specially designed equipment and platform.

          Methods

          An open-label design was followed involving administration by caretakers to 12 patients with ASD (ages:7–16). Daily 1-h sessions over 2 weeks were administered under remote supervision. The primary outcome was feasibility, which was assessed by completion rate, stimulation tolerability, and confirmation of programmed stimulation delivery. The secondary measures were initial efficacy assessed by Childhood Anxiety Sensitivity Index-Revised (CASI-R), Parent Rated Anxiety Scale for Youth with ASD (PRAS-ASD), and Clinician Global Impression (CGI) scales. Sleep measures were also tracked using Cleveland Adolescent Sleep Questionnaire (CASQ).

          Results

          Across 132 sessions, we obtained an 88.5% completion rate. A total of 22 expected adverse events were reported with headache being the most common followed by transient pain, itchiness, and stinging at the electrode site. One subject dropped out of the study unrelated to the stimulation or the study. Average scores of anxiety (CASI-R, PRAS-ASD, and CGI) and sleepiness (CASQ) were all improved at the 2 week time point. While not powered to determine efficacy, benefits were suggested in this open label pilot.

          Conclusion

          Remotely supervised, proxy-administered, at-home delivery of taVNS is feasible in patients with ASD. Initial efficacy supports pursuing larger scale trials.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options

          Since the documented observations of Kanner in 1943, there has been great debate about the diagnoses, the sub-types, and the diagnostic threshold that relates to what is now known as autism spectrum disorder (ASD). Reflecting this complicated history, there has been continual refinement from DSM-III with ‘Infantile Autism’ to the current DSM-V diagnosis. The disorder is now widely accepted as a complex, pervasive, heterogeneous condition with multiple etiologies, sub-types, and developmental trajectories. Diagnosis remains based on observation of atypical behaviors, with criteria of persistent deficits in social communication and restricted and repetitive patterns of behavior. This review provides a broad overview of the history, prevalence, etiology, clinical presentation, and heterogeneity of ASD. Factors contributing to heterogeneity, including genetic variability, comorbidity, and gender are reviewed. We then explore current evidence-based pharmacological and behavioral treatments for ASD and highlight the complexities of conducting clinical trials that evaluate therapeutic efficacy in ASD populations. Finally, we discuss the potential of a new wave of research examining objective biomarkers to facilitate the evaluation of sub-typing, diagnosis, and treatment response in ASD.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Management of children with autism spectrum disorders.

            Pediatricians have an important role not only in early recognition and evaluation of autism spectrum disorders but also in chronic management of these disorders. The primary goals of treatment are to maximize the child's ultimate functional independence and quality of life by minimizing the core autism spectrum disorder features, facilitating development and learning, promoting socialization, reducing maladaptive behaviors, and educating and supporting families. To assist pediatricians in educating families and guiding them toward empirically supported interventions for their children, this report reviews the educational strategies and associated therapies that are the primary treatments for children with autism spectrum disorders. Optimization of health care is likely to have a positive effect on habilitative progress, functional outcome, and quality of life; therefore, important issues, such as management of associated medical problems, pharmacologic and nonpharmacologic intervention for challenging behaviors or coexisting mental health conditions, and use of complementary and alternative medical treatments, are also addressed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity.

              Vagus nerve stimulation (VNS) is currently used to treat refractory epilepsy and is being investigated as a potential therapy for a range of conditions, including heart failure, tinnitus, obesity and Alzheimer's disease. However, the invasive nature and expense limits the use of VNS in patient populations and hinders the exploration of the mechanisms involved. We investigated a non-invasive method of VNS through electrical stimulation of the auricular branch of the vagus nerve distributed to the skin of the ear--transcutaneous VNS (tVNS) and measured the autonomic effects. The effects of tVNS parameters on autonomic function in 48 healthy participants were investigated using heart rate variability (HRV) and microneurography. tVNS was performed using a transcutaneous electrical nerve stimulation (TENS) machine and modified surface electrodes. Participants visited the laboratory once and received either active (200 μs, 30 Hz; n = 34) or sham (n = 14) stimulation. Active tVNS significantly increased HRV in healthy participants (P = 0.026) indicating a shift in cardiac autonomic function toward parasympathetic predominance. Microneurographic recordings revealed a significant decrease in frequency (P = 0.0001) and incidence (P = 0.0002) of muscle sympathetic nerve activity during tVNS. tVNS can increase HRV and reduce sympathetic nerve outflow, which is desirable in conditions characterized by enhanced sympathetic nerve activity, such as heart failure. tVNS can therefore influence human physiology and provide a simple and inexpensive alternative to invasive VNS. Copyright © 2014 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Psychiatry
                Front Psychiatry
                Front. Psychiatry
                Frontiers in Psychiatry
                Frontiers Media S.A.
                1664-0640
                28 September 2023
                2023
                : 14
                : 1238328
                Affiliations
                [1] 1Department of Pediatrics, Thompson Center for Autism and Neurodevelopment, University of Missouri , Columbia, MO, United States
                [2] 2School of Medicine, University of Missouri , Columbia, MO, United States
                [3] 3Department of Neurology, Thompson Center for Autism and Neurodevelopment, University of Missouri , Columbia, MO, United States
                [4] 4Research and Development, Soterix Medical , Woodbridge, NJ, United States
                [5] 5Center for Cognitive Aging and Memory, McKnight Brain Institute, University of Florida , Gainesville, FL, United States
                [6] 6Brain Rehabilitation Research Center, Malcom Randall VAMC , Gainesville, FL, United States
                [7] 7Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida , Gainesville, FL, United States
                [8] 8Department of Biomedical Engineering, City College of New York , New York, NY, United States
                [9] 9Department of Radiology, Neurology, and Psychological Sciences, and the Thompson Center for Autism and Neurodevelopment, University of Missouri-Columbia , Columbia, MO, United States
                Author notes

                Edited by: Melissa Kirkovski, Victoria University, Australia

                Reviewed by: Angelica Carandina, University of Milan, Italy; Isabelle Esther Bauer, University of Texas Health Science Center at Houston, United States

                *Correspondence: David Q. Beversdorf, beversdorfd@ 123456health.missouri.edu
                Article
                10.3389/fpsyt.2023.1238328
                10568329
                37840787
                47ba81a1-df77-4170-98c0-1e76dd67f1f1
                Copyright © 2023 Black, Hunter, Cottrell, Dar, Takahashi, Ferguson, Valter, Porges, Datta and Beversdorf.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 14 June 2023
                : 14 September 2023
                Page count
                Figures: 6, Tables: 2, Equations: 0, References: 56, Pages: 10, Words: 8181
                Funding
                AD was supported by grants from the National Institute of Health (NIH): 75N95020C00024 and 1R44MH126833-01A1, Department of Defense (DOD): W912CG21C0014, and National Aeronautics and Space Administration (NASA): 80NSSC22CA071. BB had support from the Leda J. Sears Charitable Trust, University of Missouri, Department of Pediatrics, which was the primary source of funding for this work.
                Categories
                Psychiatry
                Original Research
                Custom metadata
                Neurostimulation

                Clinical Psychology & Psychiatry
                autism spectrum disorder,tvns,tavns,vagus nerve stimulation,neuromodulation,clinical trial,home trial

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content121

                Cited by5

                Most referenced authors732